首页> 美国卫生研究院文献>OncoTargets and therapy >HOXA11-AS: a novel regulator in human cancer proliferation and metastasis
【2h】

HOXA11-AS: a novel regulator in human cancer proliferation and metastasis

机译:HOXA11-AS:一种人类癌症增殖和转移的新型调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple studies have demonstrated that lncRNAs extensively participate in human cancer proliferation and metastasis. Epigenetic modification, transcriptional and posttranscriptional regulatory mechanisms are involved in lncRNA-led tumorigenesis and transfer. Recently, a novel identified homeobox (HOX) A11 antisense lncRNA, HOXA11-AS, 1,628 bp in length, has been excessively highlighted to be an essential initiator and facilitator in the process of malignant tumor proliferation and metastasis. As found in many reports, HOXA11-AS can not only act as a molecular scaffold of PRC2, LSD1 and DNMT1 to epigenetically modify chromosomes in the nucleus but also occur as ceRNA competitively sponging miRNAs in the cytoplasm. Furthermore, HOXA11-AS may function as a potential biomarker for cancer diagnosis and prognosis. In this review, we summarize the evolvement and mechanisms of HOXA11-AS in proliferation and metastasis of various human cancers.
机译:多项研究表明,lncRNA广泛参与人类癌症的增殖和转移。表观遗传修饰,转录和转录后调控机制参与了lncRNA诱导的肿瘤发生和转移。最近,长度超过1,628 bp的新型鉴定出的同源盒(HOX)A11反义lncRNA HOXA11-AS被过度强调为恶性肿瘤增殖和转移过程中的重要启动子和促进子。正如在许多报告中发现的那样,HOXA11-AS不仅可以充当PRC2,LSD1和DNMT1的分子支架,以表观遗传方式修饰细胞核中的染色体,而且还可以作为ceRNA在细胞质中竞争性地缠绕miRNA。此外,HOXA11-AS可能用作癌症诊断和预后的潜在生物标志物。在这篇综述中,我们总结了HOXA11-AS在各种人类癌症的增殖和转移中的进化及其机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号